SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-012078
Filing Date
2021-08-26
Accepted
2021-08-26 07:16:45
Documents
21
Period of Report
2021-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plx-20210824x8k.htm   iXBRL 8-K 53666
2 EX-4.1 plx-20210824xex4d1.htm EX-4.1 100287
3 EX-4.2 plx-20210824xex4d2.htm EX-4.2 1525863
4 EX-4.3 plx-20210824xex4d3.htm EX-4.3 84650
5 EX-10.1 plx-20210824xex10d1.htm EX-10.1 403762
6 EX-10.2 plx-20210824xex10d2.htm EX-10.2 42916
7 EX-99.1 plx-20210824xex99d1.htm EX-99.1 16830
8 GRAPHIC plx-20210824xex4d2001.jpg GRAPHIC 3085
9 GRAPHIC plx-20210824xex4d2002.jpg GRAPHIC 2628
10 GRAPHIC plx-20210824xex99d1001.jpg GRAPHIC 11384
  Complete submission text file 0001558370-21-012078.txt   2707245

Data Files

Seq Description Document Type Size
11 EX-101.SCH plx-20210824.xsd EX-101.SCH 3195
12 EX-101.LAB plx-20210824_lab.xml EX-101.LAB 16162
13 EX-101.PRE plx-20210824_pre.xml EX-101.PRE 10907
14 EXTRACTED XBRL INSTANCE DOCUMENT plx-20210824x8k_htm.xml XML 4870
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 211208817
SIC: 2836 Biological Products, (No Diagnostic Substances)